ISSN: 0004-1963 eISSN: 2217-8767 Journal category: M51 Distinguished National Journal
CHARACTERIZATION OF MELOXICAM LOADED GEL-EMULSION
Scindeks Assistant Scindeks Assistant — A system for serious journals and those aspiring to become one
PDF

Abstract

Meloxicam is one of the most potent non-steroidal anti-inflammatory drugs, generally indicated for treatment of rheumatoid arthritis, osteoarthritis, and juvenile arthritis and commercially available in form of tablets and solution for IV use with recommended daily dose 7.5-15 mg. Unfortunately, long-term administration usually in higher doses is associated with increased risk of gastro-intestinal bleeding, cardiac arrest, and stroke. An alternative approach to overcome these limitations is the design of topical forms. The aim of this study is characterization and evaluation of gel-emulsion with meloxicam. The present study is focused on elaboration of gel-emulsion composed of TEGO Carbomer 134 as gelling agent, propylene glycol as solubilizer and humectant, Tween 60 and Span 60 as emulsifiers, liquid paraffin as vehicle of oil phase from gel-emulsion, triethanolamine as pH adjuster and menthol as rubefacient whereby meloxicam is incorporated as free drug in oil phase. Prepared gel-emulsion was characterized by meloxicam content, pH, spreadability, viscosity and evaluation of microbiological quality. Obtained results showed homogenous, easy spreadable, translucent gel-emulsion. Upon visual examination, no phase separation was observed. The percentage of drug content in gel-emulsion was 103%, spreadability was 9.2 cm and viscosity was 25 500 CP. Measured pH was 6.45 which is suitable for dermal application without risk of irritation. Additionally, absence of the specific microorganisms Escherichia coli, Salmonella, Pseudomonas aeruginosa, Staphylococcus aureus, Clostridia and Candida albicans was determined. The tested formulation was physicochemically stable and of adequate microbiological quality after three months of preparation, however, further research is needed to determine the safety of the developed gel-emulsion.

References

1. Mwangi AN, Njogu PM, Maru SM, Njuguna NM, Njaria PM, Kiriiri GK, Mathenge AW 2021. Meloxicam emulgels for topical management of rheumatism: Formulation development, in vitro and in vivo characterization. Saudi Pharm J. 2021 Apr;29(4):351-360. doi: 10.1016/j.jsps.2021.03.005. Epub 2021 Mar 23. PMID: 33994830; PMCID: PMC8093581.

Autori koji objavljuju u ovom časopisu pristaju na sledeće uslove:

  1. Autori zadržavaju autorska prava i pružaju časopisu pravo prvog objavljivanja rada i licenciraju ga "Creative Commons Attribution licencom" koja omogućava drugima da dele rad, uz uslov navođenja autorstva i izvornog objavljivanja u ovom časopisu.

  2. Autori mogu izraditi zasebne, ugovorne aranžmane za neekskluzivnu distribuciju članka objavljenog u časopisu (npr. postavljanje u institucionalni repozitorijum ili objavljivanje u knjizi), uz navođenje da je članak izvorno objavljen u ovom časopisu.

  3. Autorima je dozvoljeno i podstiču se da postave objavljeni članak onlajn (npr. u institucionalni repozitorijum ili na svoju internet stranicu) pre ili tokom postupka prijave rukopisa, s obzirom da takav postupak može voditi produktivnoj razmeni ideja i ranijoj i većoj citiranosti objavljenog članka (Vidi Efekti otvorenog pristupa).

Downloads

Download data is not yet available.